Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	ERCC6L CHD3 CHD4 SRCAP	1.50e-05	37	81	4	GO:0140658
GeneOntologyMolecularFunction	ATP-dependent activity	MDN1 MYL6 ERCC6L MYO18A ACIN1 CHD3 CHD4 SRCAP MYO15A ATP2B4 ABCA8	3.66e-05	614	81	11	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	MDN1 ERCC6L MYO18A ACIN1 CHD3 CHD4 SRCAP ATP2B4 ABCA8	7.36e-05	441	81	9	GO:0016887
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	9.70e-05	4	81	2	GO:0005219
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	ERCC6L MYO18A CHD3 CHD4 SRCAP	1.67e-04	127	81	5	GO:0008094
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	2.41e-04	6	81	2	GO:0048763
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPM6 STIM2 ATP2B4 RYR2 RYR3	3.73e-04	151	81	5	GO:0015085
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2D SETD7	4.48e-04	8	81	2	GO:0140945
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor 2 binding	PDCL3 CDH5	7.16e-04	10	81	2	GO:0043184
GeneOntologyMolecularFunction	protein phosphatase inhibitor activity	PPP1R2 PPP1R2B PPP1R2P1	1.10e-03	50	81	3	GO:0004864
GeneOntologyMolecularFunction	histone acetyltransferase activity	BAZ1A SRCAP KAT6B	1.16e-03	51	81	3	GO:0004402
GeneOntologyMolecularFunction	phosphatase inhibitor activity	PPP1R2 PPP1R2B PPP1R2P1	1.37e-03	54	81	3	GO:0019212
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	BAZ1A SRCAP KAT6B	1.45e-03	55	81	3	GO:0061733
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	BAZ1A SRCAP KAT6B	1.86e-03	60	81	3	GO:0034212
GeneOntologyMolecularFunction	calcium channel activity	TRPM6 STIM2 RYR2 RYR3	1.88e-03	129	81	4	GO:0005262
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor binding	PDCL3 CDH5	2.12e-03	17	81	2	GO:0005172
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR2 RYR3	2.38e-03	18	81	2	GO:0015278
GeneOntologyMolecularFunction	histone modifying activity	KMT2D BAZ1A SETD7 SRCAP KAT6B	2.40e-03	229	81	5	GO:0140993
GeneOntologyMolecularFunction	calmodulin binding	CALD1 MYO15A ATP2B4 RYR2 RYR3	2.44e-03	230	81	5	GO:0005516
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	TRPM6 STIM2 KCNK9 ATP2B4 RYR2 RYR3 TFRC	2.80e-03	465	81	7	GO:0046873
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2D SETD7	2.94e-03	20	81	2	GO:0042800
GeneOntologyMolecularFunction	helicase activity	ERCC6L CHD3 CHD4 SRCAP	3.91e-03	158	81	4	GO:0004386
GeneOntologyMolecularFunction	N-acetyltransferase activity	BAZ1A SRCAP KAT6B	3.93e-03	78	81	3	GO:0008080
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	MDN1 ERCC6L MYO18A ACIN1 CHD3 CHD4 SRCAP ATP2B4 ABCA8	4.10e-03	775	81	9	GO:0017111
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	ERCC6L MYO18A CHD3 CHD4 SRCAP	4.26e-03	262	81	5	GO:0140097
GeneOntologyMolecularFunction	histone binding	SPIN1 MLLT3 CHD3 CHD4 SRCAP	4.47e-03	265	81	5	GO:0042393
GeneOntologyBiologicalProcess	protein-DNA complex organization	BDP1 KMT2D CENPT ERCC6L UBR5 BAZ1A RRN3 SPIN1 MLLT3 CHD3 CHD4 SETD7 SRCAP KAT6B	2.01e-05	999	78	14	GO:0071824
Domain	ZF_PHD_2	KMT2D JADE3 BAZ1A ASXL3 CHD3 CHD4 KAT6B	1.65e-07	95	80	7	PS50016
Domain	ZF_PHD_1	KMT2D JADE3 BAZ1A ASXL3 CHD3 CHD4 KAT6B	1.78e-07	96	80	7	PS01359
Domain	PHD	KMT2D JADE3 BAZ1A CHD3 CHD4 KAT6B	8.12e-07	75	80	6	PF00628
Domain	Znf_PHD-finger	KMT2D JADE3 BAZ1A CHD3 CHD4 KAT6B	1.11e-06	79	80	6	IPR019787
Domain	PHD	KMT2D JADE3 BAZ1A CHD3 CHD4 KAT6B	2.24e-06	89	80	6	SM00249
Domain	Znf_PHD	KMT2D JADE3 BAZ1A CHD3 CHD4 KAT6B	2.55e-06	91	80	6	IPR001965
Domain	SNF2_N	ERCC6L CHD3 CHD4 SRCAP	1.02e-05	32	80	4	IPR000330
Domain	SNF2_N	ERCC6L CHD3 CHD4 SRCAP	1.02e-05	32	80	4	PF00176
Domain	EF-hand-dom_pair	STIM2 MYL6 DTNB TNNC2 UTRN RYR2 RYR3 CAPN11	3.14e-05	287	80	8	IPR011992
Domain	Znf_FYVE_PHD	KMT2D JADE3 BAZ1A CHD3 CHD4 KAT6B	3.99e-05	147	80	6	IPR011011
Domain	CHDCT2	CHD3 CHD4	5.42e-05	3	80	2	PF08074
Domain	CHDNT	CHD3 CHD4	5.42e-05	3	80	2	PF08073
Domain	Ryanrecept_TM4-6	RYR2 RYR3	5.42e-05	3	80	2	IPR009460
Domain	DUF1086	CHD3 CHD4	5.42e-05	3	80	2	IPR009462
Domain	DUF1087	CHD3 CHD4	5.42e-05	3	80	2	IPR009463
Domain	CHD_N	CHD3 CHD4	5.42e-05	3	80	2	IPR012958
Domain	CHD_C2	CHD3 CHD4	5.42e-05	3	80	2	IPR012957
Domain	RyR	RYR2 RYR3	5.42e-05	3	80	2	PF02026
Domain	Ryanodine_rcpt	RYR2 RYR3	5.42e-05	3	80	2	IPR003032
Domain	RR_TM4-6	RYR2 RYR3	5.42e-05	3	80	2	PF06459
Domain	DUF1087	CHD3 CHD4	5.42e-05	3	80	2	PF06465
Domain	DUF1086	CHD3 CHD4	5.42e-05	3	80	2	PF06461
Domain	DUF1087	CHD3 CHD4	5.42e-05	3	80	2	SM01147
Domain	DUF1086	CHD3 CHD4	5.42e-05	3	80	2	SM01146
Domain	Ryan_recept	RYR2 RYR3	5.42e-05	3	80	2	IPR013333
Domain	-	MYL6 DTNB TNNC2 UTRN RYR2 RYR3 CAPN11	1.28e-04	261	80	7	1.10.238.10
Domain	Zinc_finger_PHD-type_CS	JADE3 BAZ1A CHD3 CHD4	1.73e-04	65	80	4	IPR019786
Domain	Alpha_kinase	TRPM6 ALPK2	2.69e-04	6	80	2	PF02816
Domain	RIH_assoc	RYR2 RYR3	2.69e-04	6	80	2	PF08454
Domain	RIH_assoc-dom	RYR2 RYR3	2.69e-04	6	80	2	IPR013662
Domain	RIH_dom	RYR2 RYR3	2.69e-04	6	80	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	2.69e-04	6	80	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	2.69e-04	6	80	2	IPR015925
Domain	ALPHA_KINASE	TRPM6 ALPK2	2.69e-04	6	80	2	PS51158
Domain	Alpha_kinase	TRPM6 ALPK2	2.69e-04	6	80	2	SM00811
Domain	-	RYR2 RYR3	2.69e-04	6	80	2	1.25.10.30
Domain	MHCK_EF2_kinase	TRPM6 ALPK2	2.69e-04	6	80	2	IPR004166
Domain	EF-hand_dom_typ1	DTNB UTRN	2.69e-04	6	80	2	IPR015153
Domain	EF-hand_dom_typ2	DTNB UTRN	2.69e-04	6	80	2	IPR015154
Domain	RYDR_ITPR	RYR2 RYR3	2.69e-04	6	80	2	PF01365
Domain	EF-hand_2	DTNB UTRN	2.69e-04	6	80	2	PF09068
Domain	EF-hand_3	DTNB UTRN	2.69e-04	6	80	2	PF09069
Domain	Ins145_P3_rec	RYR2 RYR3	2.69e-04	6	80	2	PF08709
Domain	EF-hand_8	TNNC2 RYR2 CAPN11	4.11e-04	34	80	3	PF13833
Domain	EF_HAND_2	STIM2 MYL6 TNNC2 RYR2 RYR3 CAPN11	4.70e-04	231	80	6	PS50222
Domain	EF-hand_1	MYL6 TNNC2 RYR2 RYR3 CAPN11	4.92e-04	152	80	5	PF00036
Domain	MIR	RYR2 RYR3	7.97e-04	10	80	2	PS50919
Domain	MIR	RYR2 RYR3	7.97e-04	10	80	2	PF02815
Domain	MIR	RYR2 RYR3	7.97e-04	10	80	2	SM00472
Domain	MIR_motif	RYR2 RYR3	7.97e-04	10	80	2	IPR016093
Domain	Helicase_C	ERCC6L CHD3 CHD4 SRCAP	1.15e-03	107	80	4	PF00271
Domain	HELICc	ERCC6L CHD3 CHD4 SRCAP	1.15e-03	107	80	4	SM00490
Domain	Helicase_C	ERCC6L CHD3 CHD4 SRCAP	1.19e-03	108	80	4	IPR001650
Domain	HELICASE_CTER	ERCC6L CHD3 CHD4 SRCAP	1.23e-03	109	80	4	PS51194
Domain	HELICASE_ATP_BIND_1	ERCC6L CHD3 CHD4 SRCAP	1.23e-03	109	80	4	PS51192
Domain	DEXDc	ERCC6L CHD3 CHD4 SRCAP	1.23e-03	109	80	4	SM00487
Domain	Helicase_ATP-bd	ERCC6L CHD3 CHD4 SRCAP	1.28e-03	110	80	4	IPR014001
Domain	ZZ	DTNB UTRN	2.65e-03	18	80	2	PF00569
Domain	ZF_ZZ_2	DTNB UTRN	2.65e-03	18	80	2	PS50135
Domain	ZF_ZZ_1	DTNB UTRN	2.65e-03	18	80	2	PS01357
Domain	HMG_box_dom	KMT2D CHD3 CHD4	2.73e-03	65	80	3	IPR009071
Domain	Znf_ZZ	DTNB UTRN	2.96e-03	19	80	2	IPR000433
Domain	ZnF_ZZ	DTNB UTRN	2.96e-03	19	80	2	SM00291
Domain	EF_hand_dom	MYL6 TNNC2 RYR2 RYR3 CAPN11	3.20e-03	232	80	5	IPR002048
Domain	IQ	MYO18A MYO15A IQCD	3.51e-03	71	80	3	PF00612
Domain	EPHD	KMT2D JADE3	3.96e-03	22	80	2	PS51805
Pathway	REACTOME_MUSCLE_CONTRACTION	MYL6 CALD1 TNNC2 KCNK9 ATP2B4 RYR2 RYR3	4.28e-06	165	57	7	MM15026
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	NCOR2 KMT2D JADE3 CHD3 CHD4 SETD7 KAT6B	6.31e-06	175	57	7	MM14941
Pathway	REACTOME_MUSCLE_CONTRACTION	MYL6 CALD1 TNNC2 KCNK9 ATP2B4 RYR2 RYR3	1.66e-05	203	57	7	M5485
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	NCOR2 KMT2D JADE3 CHD3 CHD4 SETD7 KAT6B	1.07e-04	272	57	7	M29619
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	THOC1 NUP155 SRSF11 RBM8A	3.64e-04	84	57	4	M725
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	THOC1 NUP155 SRSF11 RBM8A	3.99e-04	86	57	4	MM15413
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	THOC1 BDP1 NCOR2 KMT2D NUP155 ZKSCAN1 RRN3 MLLT3 SRSF11 RBM8A CHD3 CHD4	6.63e-04	1022	57	12	MM15436
Pathway	REACTOME_CARDIAC_CONDUCTION	KCNK9 ATP2B4 RYR2 RYR3	7.89e-04	103	57	4	MM15196
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	RYR2 RYR3	8.63e-04	11	57	2	M47958
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	RRN3 CHD3 CHD4	8.96e-04	47	57	3	M1095
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	RRN3 CHD3 CHD4	8.96e-04	47	57	3	MM15428
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	THOC1 PPP1R2 PASK NCOR2 KMT2D PAXBP1 MDN1 RAPH1 ERCC6L JADE3 MYO18A ACIN1 TAOK1 RBM8A CHD3 CHD4 PATL1 KAT6B	2.28e-13	774	82	18	15302935
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	THOC1 IPO5 EMC3 MDN1 NUP155 CALD1 UBR5 BAZ1A ACIN1 SRSF11 RBM8A CHD3 CHD4 SRCAP UTRN TFRC	1.92e-09	1024	82	16	24711643
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MAP9 STIM2 MDN1 CALD1 RAPH1 BAZ1A DTNB MYO18A DNAJC21 ACIN1 SRSF11 CHD3 CHD4 PTPN21 SRCAP RYR2 CAPN11 TFRC	5.54e-09	1442	82	18	35575683
Pubmed	Structural basis for regulation of protein phosphatase 1 by inhibitor-2.	PPP1R2 PPP1R2B PPP1R2P1	1.26e-08	3	82	3	17636256
Pubmed	Cloning and characterization of human phosphatase inhibitor-2 (IPP-2) sequences.	PPP1R2 PPP1R2B PPP1R2P1	5.04e-08	4	82	3	7949733
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	THOC1 NCOR2 KMT2D PAXBP1 MDN1 MYL6 JADE3 BAZ1A UBP1 ACIN1 SRSF11 RBM8A CHD3 CHD4 MLXIP SRCAP	5.08e-08	1294	82	16	30804502
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	THOC1 IPO5 NCOR2 MDN1 NUP155 UBR5 BAZ1A NANS ACIN1 RBM8A CHD3 CHD4 MYO15A TFRC	1.02e-07	1014	82	14	32416067
Pubmed	Regulators of the protein phosphatase PP1γ2, PPP1R2, PPP1R7, and PPP1R11 are involved in epididymal sperm maturation.	PPP1R2 PPP1R2B PPP1R2P1	1.26e-07	5	82	3	30144392
Pubmed	Protein Phosphatase-1 Inhibitor-2 Is a Novel Memory Suppressor.	PPP1R2 PPP1R2B PPP1R2P1	1.26e-07	5	82	3	26558779
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	THOC1 PPP1R2 IPO5 NCOR2 CCDC9B PAXBP1 MYL6 DNAJC21 ACIN1 MLLT3 SRSF11 RBM8A CHD4 PATL1 NFU1	2.01e-07	1247	82	15	27684187
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	PAXBP1 MYL6 CALD1 RAPH1 PDCL3 ACIN1 SRSF11 CHD4 SRCAP UTRN	3.26e-07	506	82	10	30890647
Pubmed	The functional interactome landscape of the human histone deacetylase family.	IPO5 NCOR2 PAXBP1 MDN1 UBR5 ACIN1 CHD3 CHD4	4.32e-07	289	82	8	23752268
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	THOC1 MYL6 NUP155 CALD1 BAZ1A UBP1 MYO18A ACIN1 SRSF11 RBM8A TFRC	4.37e-07	660	82	11	32780723
Pubmed	Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality.	PPP1R2 PPP1R2B PPP1R2P1	4.39e-07	7	82	3	18689497
Pubmed	Primary cilia are WNT-transducing organelles whose biogenesis is controlled by a WNT-PP1 axis.	PPP1R2 PPP1R2B PPP1R2P1	7.01e-07	8	82	3	36693320
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	PPP1R2 PIK3AP1 MYL6 CALD1 RAPH1 UBR5 JADE3 NANS PDCL3 PATL1 MLXIP MAST2	7.54e-07	853	82	12	28718761
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PPP1R2 RALGAPA1 NCOR2 KMT2D EMC3 NUP155 RAPH1 DTNB SETD7 PEAK1 PTPN21 UTRN ATP2B4	1.03e-06	1049	82	13	27880917
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	IPO5 NCOR2 MDN1 NUP155 ERCC6L ACIN1 TAOK1 SRSF11 CHD3 CHD4	1.16e-06	582	82	10	20467437
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	PPP1R2 NCOR2 PPP1R2B STIM2 MYL6 CALD1 JADE3 DTNB RBM8A CHD4 UTRN NFU1	1.48e-06	910	82	12	36736316
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TRPM6 MAP9 PAXBP1 BAZ1A UBP1 SPIN1 ACIN1 TAOK1 CHD3 PATL1 PEAK1 SRCAP UTRN	1.48e-06	1084	82	13	11544199
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	KMT2D MLLT3 CHD3 CHD4 SRCAP KAT6B	2.03e-06	157	82	6	30186101
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	THOC1 NCOR2 CENPT PAXBP1 MYL6 CALD1 BAZ1A ACIN1 SRSF11 RBM8A CHD3 CHD4	2.41e-06	954	82	12	36373674
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	IPO5 MDN1 MYL6 NANS RBM8A CHD4 PEAK1 SRCAP MYO15A UTRN TFRC	3.07e-06	807	82	11	30575818
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	THOC1 PAXBP1 MYL6 BAZ1A SPIN1 ACIN1 COL14A1 TAOK1 SRSF11 RBM8A CHD3 CHD4 PATL1 ATP2B4	3.67e-06	1371	82	14	36244648
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	PAXBP1 MDN1 MYL6 BAZ1A UBP1 ACIN1 SRSF11 RBM8A CHD3 CHD4 TFRC	4.86e-06	847	82	11	35850772
Pubmed	The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.	PPP1R2 RALGAPA1 BDP1 KMT2D MLLT3	5.41e-06	106	82	5	31024071
Pubmed	Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach.	PIK3AP1 CFAP36 DNAJC21 NCKAP5 NFU1	5.41e-06	106	82	5	18654987
Pubmed	Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.	CHD3 CHD4	5.49e-06	2	82	2	7560064
Pubmed	Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa.	PPP1R2 PPP1R2B	5.49e-06	2	82	2	23506001
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	5.49e-06	2	82	2	21531043
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	5.49e-06	2	82	2	16678258
Pubmed	The metabolic sensor PASK is a histone 3 kinase that also regulates H3K4 methylation by associating with H3K4 MLL2 methyltransferase complex.	PASK KMT2D	5.49e-06	2	82	2	31529049
Pubmed	The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation.	CHD3 CHD4	5.49e-06	2	82	2	7575689
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	5.49e-06	2	82	2	8898078
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	5.49e-06	2	82	2	14550562
Pubmed	Decreased expression of ryanodine receptors alters calcium-induced calcium release mechanism in mdx duodenal myocytes.	RYR2 RYR3	5.49e-06	2	82	2	14985349
Pubmed	Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development.	CHD3 CHD4	5.49e-06	2	82	2	35568926
Pubmed	Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen.	CHD3 CHD4	5.49e-06	2	82	2	8843877
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 STIM2 MDN1 RAPH1 ERCC6L SRSF11 PEAK1 PTPN21 MLXIP MAST2 UTRN	5.68e-06	861	82	11	36931259
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	NCOR2 DNAJC21 ACIN1 SRSF11 RYR2 RYR3	6.28e-06	191	82	6	20195357
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	RALGAPA1 PAXBP1 CALD1 SRSF11 UTRN RYR2	7.49e-06	197	82	6	20811636
Pubmed	CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism.	IPO5 PDCD2 MYL6 ERCC6L CFAP36 CALCOCO1	8.40e-06	201	82	6	34917906
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RALGAPA1 PASK STIM2 EMC3 PAXBP1 MDN1 NUP155 UBR5 MYO18A DNAJC21 COL14A1 PEAK1 ATP2B4 TFRC	9.25e-06	1487	82	14	33957083
Pubmed	Functional proteomics mapping of a human signaling pathway.	NCOR2 STIM2 KMT2D NUP155 UBR5 BAZ1A CHD3 UTRN RYR2	1.08e-05	591	82	9	15231748
Pubmed	Global phosphoproteome of HT-29 human colon adenocarcinoma cells.	UBR5 MYO18A ACIN1 RBM8A	1.18e-05	59	82	4	16083285
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	PPP1R2B MYL6 CALD1 RAPH1 ERCC6L BAZ1A ACIN1 CHD3 CHD4 SRCAP UTRN	1.22e-05	934	82	11	33916271
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	IPO5 KMT2D PAXBP1 MYL6 BAZ1A ACIN1 CHD3 IQCD	1.53e-05	469	82	8	27634302
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	NCOR2 PDCD2 MDN1 NUP155 UBR5 BAZ1A NANS ACIN1 RBM8A CHD4 SRCAP UTRN TFRC	1.62e-05	1353	82	13	29467282
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR2 RYR3	1.64e-05	3	82	2	18403125
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR2 RYR3	1.64e-05	3	82	2	18434746
Pubmed	Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.	RYR2 RYR3	1.64e-05	3	82	2	29730765
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR2 RYR3	1.64e-05	3	82	2	9204703
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR2 RYR3	1.64e-05	3	82	2	7876312
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR2 RYR3	1.64e-05	3	82	2	21881589
Pubmed	Not so pseudo: the evolutionary history of protein phosphatase 1 regulatory subunit 2 and related pseudogenes.	PPP1R2 PPP1R2B	1.64e-05	3	82	2	24195737
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR2 RYR3	1.64e-05	3	82	2	12213830
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR2 RYR3	1.64e-05	3	82	2	9242641
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR2 RYR3	1.64e-05	3	82	2	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR2 RYR3	1.64e-05	3	82	2	10788707
Pubmed	RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle.	RYR2 RYR3	1.64e-05	3	82	2	15024040
Pubmed	The chromatin-remodeling enzyme CHD3 plays a role in embryonic viability but is dispensable for early vascular development.	CHD3 CHD4	1.64e-05	3	82	2	32658897
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR2 RYR3	1.64e-05	3	82	2	25239916
Pubmed	The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.	KMT2D CHD3	1.64e-05	3	82	2	26551667
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR2 RYR3	1.64e-05	3	82	2	7621815
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR2 RYR3	1.64e-05	3	82	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR2 RYR3	1.64e-05	3	82	2	11159936
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR2 RYR3	1.64e-05	3	82	2	10473538
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR2 RYR3	1.64e-05	3	82	2	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR2 RYR3	1.64e-05	3	82	2	4600883
Pubmed	Re-examination of siRNA specificity questions role of PICH and Tao1 in the spindle checkpoint and identifies Mad2 as a sensitive target for small RNAs.	ERCC6L TAOK1	1.64e-05	3	82	2	19904549
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR2 RYR3	1.64e-05	3	82	2	7635066
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	THOC1 KMT2D CHD4 SRCAP	2.21e-05	69	82	4	28481362
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	RAPH1 BAZ1A ASXL3 PDCL3 CALCOCO1 SRSF11 MAST2	2.39e-05	361	82	7	26167880
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	IPO5 MDN1 TAOK1 NCKAP5 SRCAP MAST2 UTRN	2.47e-05	363	82	7	14691545
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	UBR5 DTNB USP4 CHD4 UTRN	2.65e-05	147	82	5	29576527
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	THOC1 TRPM6 IPO5 PAXBP1 MDN1 MYL6 NUP155 BAZ1A ACIN1 CHD4 PEAK1 MAST2 TFRC	2.79e-05	1425	82	13	30948266
Pubmed	Characterization of the CHD family of proteins.	CHD3 CHD4	3.28e-05	4	82	2	9326634
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR2 RYR3	3.28e-05	4	82	2	18206662
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR2 RYR3	3.28e-05	4	82	2	23413940
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR2 RYR3	3.28e-05	4	82	2	9384575
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR2 RYR3	3.28e-05	4	82	2	9607712
Pubmed	NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.	CHD3 CHD4	3.28e-05	4	82	2	16574654
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR2 RYR3	3.28e-05	4	82	2	23482488
Pubmed	Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome.	DTNB UTRN RYR2	3.55e-05	27	82	3	18468998
Pubmed	Luzp4 defines a new mRNA export pathway in cancer cells.	THOC1 CALD1 ACIN1 RBM8A	3.96e-05	80	82	4	25662211
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	RALGAPA1 NCOR2 MDN1 MYL6 UBR5 CHD3 KAT6B UTRN	4.07e-05	538	82	8	28524877
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 PKNOX2 BDP1 NCOR2 CALD1 DTNB SPIN1 CALCOCO1 SRSF11 CHD3 PATL1 KAT6B UTRN	4.38e-05	1489	82	13	28611215
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	KMT2D TRANK1 MYL6 ASXL3 TAOK1 MLXIP UTRN ATP2B4	4.87e-05	552	82	8	10737800
Pubmed	Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin.	KMT2D MYL6 ACIN1 RBM8A CHD4	5.30e-05	170	82	5	16159877
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	THOC1 IPO5 KMT2D PAXBP1 ACIN1 CHD3 UTRN	5.34e-05	410	82	7	26949251
Pubmed	Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome.	PPP1R2 PPP1R2B PPP1R2P1	5.41e-05	31	82	3	15778864
Pubmed	Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.	RYR2 RYR3	5.47e-05	5	82	2	33060591
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR2 RYR3	5.47e-05	5	82	2	23918386
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR2 RYR3	5.47e-05	5	82	2	19011160
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	KLHL38 RALGAPA1 STIM2 ERCC6L DTNB PEAK1 ATP2B4 TFRC	6.02e-05	569	82	8	30639242
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NCOR2 KMT2D RAPH1 UBR5 CHD3 CHD4 UTRN	6.03e-05	418	82	7	34709266
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PASK NCOR2 MYL6 UBR5 CFAP36 CHD3 CHD4 SRCAP KAT6B MAST2 ABCA8	6.17e-05	1116	82	11	31753913
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	THOC1 MDN1 NUP155 BAZ1A MYO18A DNAJC21 ACIN1 CHD3 CHD4	7.58e-05	759	82	9	35915203
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	RYR2 RYR3	8.19e-05	6	82	2	19549818
Pubmed	Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.	RYR2 RYR3	8.19e-05	6	82	2	26025922
Interaction	NUP43 interactions	NCOR2 KMT2D CENPT PAXBP1 UBR5 JADE3 BAZ1A PDCL3 ACIN1 CHD3 SRCAP RYR2	7.14e-06	625	81	12	int:NUP43
Interaction	SRRM1 interactions	KMT2D CALD1 UBR5 ACIN1 USP4 SRSF11 RBM8A CHD3 CHD4	1.08e-05	348	81	9	int:SRRM1
Interaction	ZNF622 interactions	PPP1R2 UBR5 DNAJC21 RBM8A CHD3 CHD4	1.23e-05	127	81	6	int:ZNF622
Interaction	SF3A1 interactions	THOC1 PAXBP1 ASXL3 ACIN1 USP4 RBM8A CHD3 CHD4 PATL1 SRCAP	1.88e-05	471	81	10	int:SF3A1
Interaction	YWHAG interactions	RALGAPA1 LNP1 STIM2 MDN1 RAPH1 ERCC6L BAZ1A ACIN1 TAOK1 SRSF11 PEAK1 PTPN21 MLXIP MAST2 KCNK9 UTRN	3.12e-05	1248	81	16	int:YWHAG
Interaction	KDR interactions	MDN1 NUP155 BAZ1A PDCL3 ACIN1 CDH5	3.15e-05	150	81	6	int:KDR
Interaction	CALM1 interactions	STIM2 MYL6 CALD1 ZKSCAN1 UBR5 MYO18A RBM8A PEAK1 UTRN ATP2B4 RYR2	4.01e-05	626	81	11	int:CALM1
Interaction	PRP4K interactions	THOC1 PAXBP1 UBR5 BAZ1A ACIN1 SRSF11 RBM8A CHD4	5.29e-05	329	81	8	int:PRP4K
Interaction	OBSL1 interactions	THOC1 PASK MDN1 NUP155 CALD1 ACIN1 SRSF11 RBM8A CHD4 PTPN21 SRCAP UTRN ALPK2	5.92e-05	902	81	13	int:OBSL1
Interaction	SARNP interactions	THOC1 UBR5 ACIN1 CHD3 SRCAP ABCA8	5.94e-05	168	81	6	int:SARNP
Interaction	TWIST1 interactions	MYL6 NUP155 UBR5 USP4 CHD3 CHD4	6.34e-05	170	81	6	int:TWIST1
Interaction	AGR2 interactions	THOC1 KLHL38 IPO5 MDN1 MYL6 NANS RBM8A CHD4 PEAK1 SRCAP MYO15A UTRN TFRC	8.43e-05	934	81	13	int:AGR2
Interaction	NUPR1 interactions	THOC1 MYL6 NUP155 CALD1 BAZ1A UBP1 MYO18A ACIN1 SRSF11 RBM8A TFRC	8.77e-05	683	81	11	int:NUPR1
Interaction	THOC7 interactions	THOC1 PPP1R2 CCDC9B RBM8A CHD3	9.65e-05	114	81	5	int:THOC7
Interaction	ACTC1 interactions	PAXBP1 MYL6 CALD1 RAPH1 PDCL3 ACIN1 SRSF11 CHD3 CHD4 SRCAP UTRN	1.01e-04	694	81	11	int:ACTC1
Interaction	GSK3A interactions	PPP1R2 PASK PPP1R2B MDN1 UBR5 ACIN1 RBM8A PEAK1 UTRN	1.01e-04	464	81	9	int:GSK3A
Interaction	SUMO2 interactions	IPO5 MDN1 BAZ1A ACIN1 RBM8A CHD3 CHD4 SRCAP MAST2 ABCA8	1.26e-04	591	81	10	int:SUMO2
Interaction	PAXBP1 interactions	THOC1 PAXBP1 UBR5 CHD3 CHD4	1.28e-04	121	81	5	int:PAXBP1
Interaction	RNF2 interactions	THOC1 KMT2D CCDC9B UBR5 OTUD6A DNAJC21 ACIN1 MLLT3 RBM8A CHD3 CHD4 TFRC	1.69e-04	866	81	12	int:RNF2
Interaction	PPP1CC interactions	PPP1R2 PPP1R2B MYL6 CALD1 RAPH1 UBR5 ACIN1 CHD3 CHD4 PEAK1 RYR2	1.73e-04	738	81	11	int:PPP1CC
Interaction	CEBPB interactions	THOC1 IPO5 PIK3AP1 NCOR2 KMT2D MYL6 BAZ1A NANS UBP1 SPIN1 ACIN1 MLLT3 SRSF11 RBM8A CHD4 TFRC	1.73e-04	1443	81	16	int:CEBPB
Interaction	ZBTB7A interactions	NCOR2 MDN1 UBR5 CHD3 CHD4	1.85e-04	131	81	5	int:ZBTB7A
Interaction	THOC1 interactions	THOC1 CCDC9B PAXBP1 RBM8A CHD4 UTRN	2.02e-04	210	81	6	int:THOC1
Interaction	ACIN1 interactions	UBR5 ACIN1 USP4 SRSF11 RBM8A CHD3 CHD4	2.09e-04	301	81	7	int:ACIN1
Interaction	PLAC9 interactions	EMC3 MYO18A ATP2B4	2.12e-04	29	81	3	int:PLAC9
Interaction	MEN1 interactions	THOC1 KMT2D PAXBP1 MDN1 UBR5 BAZ1A ACIN1 RBM8A CHD3 CHD4 SRCAP KAT6B TFRC	2.20e-04	1029	81	13	int:MEN1
Interaction	SAP18 interactions	CALD1 UBR5 ACIN1 SRSF11 RBM8A CHD3 CHD4	2.27e-04	305	81	7	int:SAP18
Interaction	SUPT5H interactions	THOC1 NCOR2 KMT2D UBR5 ACIN1 RBM8A CHD3 CHD4	2.33e-04	408	81	8	int:SUPT5H
GeneFamily	PHD finger proteins	KMT2D JADE3 BAZ1A CHD3 CHD4 KAT6B	3.42e-07	90	56	6	88
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	2.82e-05	3	56	2	287
GeneFamily	EF-hand domain containing	MYL6 TNNC2 RYR2 RYR3 CAPN11	5.76e-04	219	56	5	863
GeneFamily	PHD finger proteins\|NuRD complex	CHD3 CHD4	6.10e-04	12	56	2	1305
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DTNB UTRN	1.40e-03	18	56	2	91
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 KMT2D	2.70e-03	25	56	2	775
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2D SETD7	4.96e-03	34	56	2	487
Coexpression	KARLSSON_TGFB1_TARGETS_UP	PPP1R2 IPO5 PPP1R2B BAZ1A PPP1R2P1 CHD3	2.98e-06	127	82	6	MM1289
Coexpression	GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN	THOC1 PIK3AP1 JADE3 NANS DNAJC21 CD79B RBM8A	3.18e-06	200	82	7	M6989
Coexpression	VANASSE_BCL2_TARGETS_UP	PPP1R2 PPP1R2B PPP1R2P1 RYR2	1.00e-05	43	82	4	MM799
Coexpression	LEE_AGING_MUSCLE_DN	PPP1R2 PPP1R2B PPP1R2P1 USP4	1.31e-05	46	82	4	MM670
Coexpression	NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	IPO5 PASK UBR5 BAZ1A NANS SPIN1 USP4 MAST2	1.98e-05	367	82	8	M41159
Coexpression	GABRIELY_MIR21_TARGETS	CALD1 RAPH1 UBR5 SPIN1 SRSF11 UTRN ATP2B4	3.46e-05	289	82	7	M2196
Coexpression	MURARO_PANCREAS_BETA_CELL	PPP1R2 NCOR2 RAPH1 RRN3 CFAP36 SPIN1 TAOK1 PATL1 VAT1L SETD7 KAT6B UTRN	3.69e-05	946	82	12	M39169
Coexpression	GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN	THOC1 PIK3AP1 JADE3 SPIN1 CD79B MAST2	3.96e-05	200	82	6	M8096
Coexpression	GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN	CENPT ERCC6L BAZ1A PDCL3 CD79B NFU1	3.96e-05	200	82	6	M6601
Coexpression	OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP	MYL6 ACIN1 CHD4 KAT6B ATP2B4	9.68e-05	146	82	5	M41190
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	IPO5 RALGAPA1 PDCD2 MDN1 UBR5 BAZ1A RRN3 PDCL3 ANKRD10 USP4 RBM8A NFU1 RYR3	9.71e-05	1215	82	13	M41122
Coexpression	GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP	COL14A1 CD79B PATL1 MYO15A KCNK9	1.06e-04	149	82	5	M2908
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	CALD1 NCKAP5 MAST2 ATP2B4 ALPK2 RYR2	1.31e-06	190	81	6	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	MYL6 CALD1 ZKSCAN1 BAZ1A MLLT3 SETD7	1.57e-06	196	81	6	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	MYL6 CALD1 ZKSCAN1 BAZ1A MLLT3 SETD7	1.57e-06	196	81	6	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	TCGA-Lung-Solid_Tissue_Normal\|TCGA-Lung / Sample_Type by Project: Shred V9	PKNOX2 NCKAP5 PTPN21 CDH5 ABCA8	1.31e-05	166	81	5	a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung\|TCGA-Lung / Sample_Type by Project: Shred V9	PKNOX2 NCKAP5 PTPN21 CDH5 ABCA8	1.31e-05	166	81	5	c64971c27cb445dffc5a636d4b6a60261b93a2db
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue\|TCGA-Lung / Sample_Type by Project: Shred V9	PKNOX2 NCKAP5 PTPN21 CDH5 ABCA8	1.31e-05	166	81	5	2f3072a7af048f184d33065fdd36153fd563155a
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6\|TCGA-Lung / Sample_Type by Project: Shred V9	PKNOX2 NCKAP5 PTPN21 CDH5 ABCA8	1.31e-05	166	81	5	188f2575511f418216874aed9118aa6f165252cb
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	TRPM6 JADE3 ASXL3 CHD3 ALPK2	1.52e-05	171	81	5	ce290930385cac35dbd21a5e91cf0f93cf3e99f8
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PKNOX2 CALD1 MLLT3 NCKAP5 RYR2	1.84e-05	178	81	5	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	AT1_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	CCDC9B NCKAP5 PEAK1 PTPN21 ABCA8	1.94e-05	180	81	5	e1964002681f80d8d62406b6ee52a01e1829ccf2
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRANK1 ASXL3 MYO15A RYR2 RYR3	2.16e-05	184	81	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 CALD1 RAPH1 COL14A1 ABCA8	2.16e-05	184	81	5	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRANK1 ASXL3 MYO15A RYR2 RYR3	2.16e-05	184	81	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRANK1 ASXL3 MYO15A RYR2 RYR3	2.16e-05	184	81	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	NCKAP5 MAST2 ATP2B4 ALPK2 RYR2	2.45e-05	189	81	5	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	(04)_Pre-ciliated\|World / shred by cell type and Timepoint	LRRC46 MAP9 JADE3 CFAP36 MAST2	2.58e-05	191	81	5	37cf121e6e80760c8519075b7845b9029958a988
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYL6 CALD1 COL14A1 TNNC2 ATP2B4	2.71e-05	193	81	5	88916d9a7d831eb52848599917c04238f8f9812b
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	PASK MYL6 TAOK1 PATL1 TFRC	2.78e-05	194	81	5	6cf9d59aec8dd18fa2fc1652ddd0f5ef1f24bcb6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 TRANK1 CALD1 RAPH1 ABCA8	2.78e-05	194	81	5	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 TRANK1 CALD1 RAPH1 ABCA8	2.78e-05	194	81	5	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Central_Memory_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PASK MYL6 NANS PDCL3 RBM8A	2.85e-05	195	81	5	0a200e43e861d5a24c07244c576bba5d67efcf2d
ToppCell	ASK452\|World / Donor, Lineage and Cell class of Lung cells from Dropseq	CALD1 BAZ1A COL14A1 TAOK1 RYR2	2.85e-05	195	81	5	7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCKAP5 PEAK1 PTPN21 UTRN ABCA8	2.92e-05	196	81	5	6731fef8c148b6681d6ed38afdf23c8213e0bbbe
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NCOR2 CALD1 ANKRD10 CDH5 RYR3	2.92e-05	196	81	5	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	2.92e-05	196	81	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCKAP5 PEAK1 PTPN21 UTRN ABCA8	2.92e-05	196	81	5	6856317cd0cdcb88fe54b4ae905d91e13495b1c4
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	IPO5 PKNOX2 PDCD2 NANS PDCL3	2.99e-05	197	81	5	ec92d60f802c9d4bdf9877bed5c0a91a5a5ed5d0
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	2.99e-05	197	81	5	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	IPO5 PKNOX2 PDCD2 NANS PDCL3	2.99e-05	197	81	5	7bec9c1bc8851064eb229324493b47a31201c83c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	PKNOX2 COL14A1 ABCA8 RYR2 RYR3	3.07e-05	198	81	5	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	3.07e-05	198	81	5	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	MAP9 STIM2 EMC3 BAZ1A UTRN	3.07e-05	198	81	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	3.07e-05	198	81	5	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	3.14e-05	199	81	5	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	3.22e-05	200	81	5	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 PAXBP1 ACIN1 SRSF11 UTRN	3.22e-05	200	81	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	3.22e-05	200	81	5	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	3.22e-05	200	81	5	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	TRANK1 PEAK1 SRCAP UTRN ATP2B4	3.22e-05	200	81	5	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PKNOX2 CALD1 COL14A1 ABCA8 RYR2	3.22e-05	200	81	5	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	CCDC9B CALD1 RYR2 RYR3	1.75e-04	153	81	4	ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MYO18A NCKAP5 PEAK1	1.79e-04	60	81	3	28415d543aaccc74d19e1bb92b7e6fa94f97f8f2
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MYO18A NCKAP5 PEAK1	1.79e-04	60	81	3	71eba0fbef11cfc2b1c525d5f051530750e4fce9
ToppCell	Club_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	ASXL3 MLLT3 NCKAP5 VAT1L	2.02e-04	159	81	4	a7bcff268b1962a561fd2848e01ae16565bce895
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	CALD1 COL14A1 RYR2 RYR3	2.12e-04	161	81	4	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	normal-na-Lymphocytic_T-T4_reg-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PPP1R2 MYO18A CHD3 ABCA8	2.22e-04	163	81	4	43887e7687fc6367efac0c1f56a9534b06f47b7f
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CCDC9B CENPT DTNB ARMC9	2.28e-04	164	81	4	d6806deabf5f5c355934387be2baae125ac33fb8
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	NCKAP5 PEAK1 PTPN21 ABCA8	2.55e-04	169	81	4	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|367C / Donor, Lineage, Cell class and subclass (all cells)	PKNOX2 CALD1 COL14A1 ABCA8	2.55e-04	169	81	4	47fd4adfe54777e69a0fabf8bd34f26223f63275
ToppCell	367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	PKNOX2 CALD1 COL14A1 ABCA8	2.55e-04	169	81	4	e09259d62cd3e42f0919f231ed1164db59b0b6c3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 CALD1 COL14A1 ABCA8	2.55e-04	169	81	4	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RALGAPA1 KAT6B UTRN TFRC	2.67e-04	171	81	4	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 RAPH1 COL14A1 ABCA8	2.73e-04	172	81	4	1ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 RAPH1 COL14A1 ABCA8	2.73e-04	172	81	4	ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	NCKAP5 PEAK1 UTRN ABCA8	2.79e-04	173	81	4	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	CALD1 COL14A1 RYR2 RYR3	2.79e-04	173	81	4	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PKNOX2 CALD1 COL14A1 RYR2	2.85e-04	174	81	4	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 RAPH1 VAT1L PEAK1	2.91e-04	175	81	4	1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f
ToppCell	COVID-19_Mild-Neu_3\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	KMT2D RRN3 SETD7 UTRN	2.98e-04	176	81	4	2049767fd591045cfcf5b1071d80798e52843f27
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PASK PDCD2 UBP1 ABCA8	2.98e-04	176	81	4	e08e7a6dd0208acfbb8646d71915af822a64b5de
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PASK PDCD2 UBP1 ABCA8	2.98e-04	176	81	4	b8264cdda75c5145d8bf8ae00b3e05393fe9a92b
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PASK PDCD2 UBP1 ABCA8	2.98e-04	176	81	4	4aee9fdada077db7e531684ab938153f84dc8146
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CALD1 COL14A1 ABCA8 RYR2	3.04e-04	177	81	4	cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	CALD1 COL14A1 ABCA8 RYR2	3.04e-04	177	81	4	db222faaecbe5600da39277243c4e7e764eb63c9
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALD1 PEAK1 UTRN CDH5	3.11e-04	178	81	4	ad3de3e03a401dac64431a541899445262246347
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	PDCL3 COL14A1 CHD3 TNNC2	3.17e-04	179	81	4	5f7e6670a0e906a0a5bc75735408361d88e78fa2
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	NCKAP5 TNNC2 PTPN21 ABCA8	3.24e-04	180	81	4	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 RAPH1 VAT1L PEAK1	3.31e-04	181	81	4	a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	STIM2 PAXBP1 UTRN ATP2B4	3.31e-04	181	81	4	986c036e656f24fe374807e2711cec9e3c83c892
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALD1 PEAK1 UTRN CDH5	3.31e-04	181	81	4	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 RAPH1 VAT1L PEAK1	3.31e-04	181	81	4	526e858a848470b6d2d5248788004d9735ed3add
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PKNOX2 CALD1 ABCA8 RYR2	3.31e-04	181	81	4	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYL6 CALD1 ARMC9 ATP2B4	3.31e-04	181	81	4	beb2771820956be8b190c0088ae3c4efdb53c897
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	NCKAP5 ATP2B4 ALPK2 RYR2	3.38e-04	182	81	4	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD3 CHD4 PEAK1 UTRN	3.38e-04	182	81	4	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYL6 CALD1 UTRN ATP2B4	3.38e-04	182	81	4	ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD3 CHD4 PEAK1 UTRN	3.38e-04	182	81	4	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PPP1R2 PEAK1 UTRN CDH5	3.38e-04	182	81	4	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRC46 CFAP36 TNNC2 IQCD	3.38e-04	182	81	4	59fdffe9485b8e464c7db6b387f5a9aa8921ff06
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PPP1R2 PEAK1 UTRN CDH5	3.38e-04	182	81	4	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PPP1R2 PEAK1 UTRN CDH5	3.38e-04	182	81	4	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRANK1 BAZ1A TAOK1 UTRN	3.45e-04	183	81	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	CCDC9B NCKAP5 PTPN21 ABCA8	3.45e-04	183	81	4	6821dca076318115d360ff426eb1218cfe104063
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PKNOX2 UTRN CDH5 ATP2B4	3.52e-04	184	81	4	087666ba949b129c53d7ace40f9e543e3875a7de
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYL6 CALD1 UTRN ATP2B4	3.52e-04	184	81	4	94748f63947db79a6b4540e3090a63689fdd9452
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCKAP5 PEAK1 PTPN21 UTRN	3.52e-04	184	81	4	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	COL14A1 SETD7 UTRN ABCA8	3.52e-04	184	81	4	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 CALD1 COL14A1 ABCA8	3.52e-04	184	81	4	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYL6 CALD1 UTRN ATP2B4	3.52e-04	184	81	4	819b277ecced7b415e363c7e7ddbc6f3b2d296de
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCKAP5 PEAK1 PTPN21 UTRN	3.52e-04	184	81	4	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKNOX2 CENPT CDH5 ATP2B4	3.60e-04	185	81	4	eeb6f55a6f79adf80247baa2c4b0df44553557ad
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	KMT2D NUP155 MAST2 TFRC	3.60e-04	185	81	4	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC46 MDN1 ARMC9 RYR3	3.60e-04	185	81	4	bb5a4cf93534b9bcd0923f314c389d571e91e7f8
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	PKNOX2 CALD1 NCKAP5 RYR2	3.60e-04	185	81	4	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP9 STIM2 MLLT3 ATP2B4	3.60e-04	185	81	4	f1263899a2d41d182022dc4ca62cbae08a463c89
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NUP155 ASXL3 PTPN21 CDH5	3.67e-04	186	81	4	39e475a3c167b33daa63b0c1bfa32451c5f46635
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALD1 COL14A1 ABCA8 RYR2	3.67e-04	186	81	4	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	COPD-Stromal-Pericyte\|World / Disease state, Lineage and Cell class	PKNOX2 CALD1 NCKAP5 RYR2	3.67e-04	186	81	4	8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NUP155 ASXL3 PTPN21 CDH5	3.67e-04	186	81	4	02418c50fdcca549bf73dedf6199ab4a27862a9b
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRANK1 CHD3 ATP2B4 RYR2	3.67e-04	186	81	4	7278a1a1bf9bb27aeb03852134defb31b62f30d6
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	IPO5 PASK PDCD2 CHD3 PTPN21 MAST2 RYR2	6.83e-06	198	81	7	6444_DN
Drug	Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A	PASK NCOR2 MYL6 CALD1 DTNB PTPN21 MAST2	6.83e-06	198	81	7	7501_DN
Drug	mag-fura-2	TRPM6 ATP2B4 RYR2 RYR3	8.98e-06	37	81	4	CID000123839
Drug	K-Cl	MYL6 CALD1 DTNB MYO18A TNNC2 MYO15A KCNK9 ATP2B4 RYR2 RYR3	3.26e-05	567	81	10	CID000004873
Drug	2-hydroxycarbazole	RYR2 RYR3	3.74e-05	3	81	2	CID000093551
Drug	cis-diammineplatinum(II	RYR2 RYR3	3.74e-05	3	81	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR2 RYR3	3.74e-05	3	81	2	CID002750949
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR2 RYR3	3.74e-05	3	81	2	CID005748312
Drug	8N3-cADPR	RYR2 RYR3	3.74e-05	3	81	2	CID000127713
Drug	aminodantrolene	RYR2 RYR3	3.74e-05	3	81	2	CID009570289
Drug	MgCl2	MYL6 CALD1 DTNB MYO18A USP4 TNNC2 MYO15A ATP2B4	3.78e-05	354	81	8	CID000024584
Drug	AC1L380G	TNNC2 RYR2 RYR3	4.03e-05	19	81	3	CID000084698
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	THOC1 PASK MLXIP KAT6B MAST2 TFRC	6.20e-05	191	81	6	1057_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	ZKSCAN1 SPIN1 SRSF11 CHD3 PTPN21 UTRN	6.39e-05	192	81	6	5058_DN
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A	PKNOX2 KMT2D CALD1 COL14A1 SRCAP ATP2B4	6.39e-05	192	81	6	5575_UP
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A	RALGAPA1 PASK CALD1 CHD3 PTPN21 UTRN	6.76e-05	194	81	6	4572_DN
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	IPO5 MAP9 PDCD2 CENPT CHD4 MAST2	6.96e-05	195	81	6	6561_UP
Drug	doxorubicinol	PDCD2 RYR2 TFRC	7.30e-05	23	81	3	CID000083970
Drug	PCB74	RYR2 RYR3	7.47e-05	4	81	2	CID000036218
Drug	148504-47-6	RYR2 RYR3	7.47e-05	4	81	2	CID006444275
Drug	SC 38249	RYR2 RYR3	7.47e-05	4	81	2	CID000134834
Drug	AC1L1U7A	RYR2 RYR3	7.47e-05	4	81	2	CID000035682
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A	PKNOX2 COL14A1 CD79B SRCAP UTRN RYR2	7.57e-05	198	81	6	6496_UP
Drug	Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A	PKNOX2 PASK PTPN21 UTRN ATP2B4 RYR2	7.78e-05	199	81	6	3249_UP
Drug	Norethindrone [68-22-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PASK CENPT ZKSCAN1 CALCOCO1 PTPN21 ATP2B4	8.00e-05	200	81	6	5474_DN
Drug	strontium	TNNC2 ATP2B4 RYR2 RYR3	1.02e-04	68	81	4	CID000104798
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	2.07e-05	3	78	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	2.07e-05	3	78	2	DOID:8545 (implicated_via_orthology)
Disease	amino acid measurement	IPO5 PASK COL14A1 CD79B VAT1L SETD7 MLXIP RYR2 RYR3	7.52e-05	678	78	9	EFO_0005134
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	DTNB UTRN CAPN11	1.19e-04	36	78	3	DOID:11723 (implicated_via_orthology)
Disease	Alzheimer disease, survival time	PKNOX2 NCKAP5	1.91e-04	8	78	2	EFO_0000714, MONDO_0004975
Disease	gastric adenocarcinoma (is_implicated_in)	KMT2D UBR5	3.74e-04	11	78	2	DOID:3717 (is_implicated_in)
Disease	Metastatic melanoma	PASK PEAK1 ALPK2	4.00e-04	54	78	3	C0278883
Disease	testosterone measurement	TRPM6 PKNOX2 NCOR2 ERCC6L SPIN1 PTPN21 SRCAP MYO15A UTRN ATP2B4 ABCA8	5.13e-04	1275	78	11	EFO_0004908
Disease	ascending aortic diameter	KLHL38 CCDC9B KCNK9 RYR2	5.27e-04	140	78	4	EFO_0021787
Disease	T-Cell Lymphoma	KMT2D ASXL3	8.08e-04	16	78	2	C0079772
Disease	pulmonary hypertension (biomarker_via_orthology)	CDH5 RYR2 RYR3	1.26e-03	80	78	3	DOID:6432 (biomarker_via_orthology)
Disease	colon adenocarcinoma (is_implicated_in)	UBR5 CHD4	2.15e-03	26	78	2	DOID:234 (is_implicated_in)
Disease	red blood cell density measurement	RALGAPA1 UBR5 BAZ1A CHD4 MYO15A MAST2 ATP2B4 TFRC	2.26e-03	880	78	8	EFO_0007978
Disease	RS-10-hydroxywarfarin measurement	TRPM6 VAT1L ATP2B4	2.26e-03	98	78	3	EFO_0803330
Disease	Sezary Syndrome	KMT2D CHD3	2.32e-03	27	78	2	C0036920

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELEEASAESEDEMIH	ACIN1	161	Q9UKV3
HMEDQSRKDFEEEDV	BDP1	751	A6H8Y1
TNGDTEDDADKMHVD	ANKRD10	241	Q9NXR5
TEHVFLLESDDEEME	ALPK2	351	Q86TB3
MGEKQEELEDLDAVH	IQCD	341	Q96DY2
IMKDLHSDDNEEESD	MLLT3	406	P42568
DGSDVVSDLEHEEMK	CFAP36	141	Q96G28
EKVSEDDMDQDFLHL	CAPN11	561	Q9UMQ6
KEELMHGEEADAVYE	PIK3AP1	406	Q6ZUJ8
AAMIEVKKDEADHDG	CDH5	706	P33151
LDKDDSKAGMEEDHT	CD79B	181	P40259
KDAEGLDEIDHAEME	ATP2B4	1071	P23634
ELHEADKGFRMDTED	ASXL3	1671	Q9C0F0
DQDMVTEDEDDPGSH	BAZ1A	726	Q9NRL2
MEQLSDEEIDHGAEE	RAPH1	1	Q70E73
AMDEDGDESIHKLKE	RBM8A	16	Q9Y5S9
DSHMESAEVEKEELP	KAT6B	1431	Q8WYB5
FDALESDHEMREEEK	KCNK9	26	Q9NPC2
EMSEHLAGFKREEEE	OTUD6A	116	Q7L8S5
SGNEEEMVEEAEALH	NCOR2	711	Q9Y618
GERDEMDLLGDHEEN	PATL1	71	Q86TB9
SDVVEALSEEHMEAD	PASK	176	Q96RG2
MEHKDDDDDDVSFAK	LNP1	1	A1A4G5
EDFDGKMHDGELEEQ	MDN1	4731	Q9NU22
KMHDGELEEQEEDDE	MDN1	4736	Q9NU22
SHMEEKDGLEDKETA	MAP9	186	Q49MG5
AGSEEDDEVVAMIKE	NFU1	161	Q9UMS0
AHAMDDIAELEEPED	MYO15A	426	Q9UKN7
HDDDKVEEMLETAHG	PPP1R2P1	166	Q96PQ5
EEDHDIMEADLDKDE	ARMC9	591	Q7Z3E5
NEMLEDEDAEDHGGT	CCDC9B	141	Q6ZUT6
TEEEVEMLVAGHEDS	MYL6	121	P60660
EALEEELDSMAKHES	PDCD2	221	Q16342
HSKEMESRDEEVEEA	MYO18A	1586	Q92614
MTLEELEDHEDEFNE	PDCL3	51	Q9H2J4
SEEDVLFSNMEEEHE	PEAK1	236	Q9H792
EDGELSEKMFHTLDE	LRRC46	31	Q96FV0
EHGEDEMDMESEKEE	PAXBP1	181	Q9Y5B6
DGSDENEMEEHELKD	DNAJC21	281	Q5F1R6
NEMEEHELKDEEDGK	DNAJC21	286	Q5F1R6
IIAEGEMHEAIKHED	IPO5	1041	O00410
ISKDLHDDDEDEEML	PPP1R2	161	P41236
ADGEFLHELEEKMEV	NUP155	1136	O75694
MLIHSSEEEEDEDFE	PTPN21	706	Q16825
HKDEDLSSLVQDDDM	MLXIP	236	Q9HAP2
EGEKEEEDDHMEYCR	CHD3	446	Q12873
DEKEMKIGETHTDIE	COL14A1	486	Q05707
LHDGVEEAEKKMEEE	CENPT	326	Q96BT3
LHSAEEGAEEEEEKM	DTNB	606	O60941
HHMDSEDEEEVSEDG	MAST2	821	Q6P0Q8
DVEEELMAKDLHFEG	EMC3	236	Q9P0I2
EVGGDLEEEDDHHME	CHD4	436	Q14839
TLDTEEEEDDTIHMG	RYR2	2371	Q92736
EEDHLKAEARGDMSE	RYR2	3336	Q92736
ESDKDALEDHMDGHF	CALCOCO1	666	Q9P1Z2
MMAAHDDSLDGTEEE	PKNOX2	421	Q96KN3
EHGLEMKTILDEGDE	JADE3	341	Q92613
HVEDMEERLDDSSEA	ERCC6L	1106	Q2NKX8
EGLFNMDEDEETEHE	RRN3	281	Q9NYV6
MDEDEETEHETKAGP	RRN3	286	Q9NYV6
KHLESSDEDEKMDEE	UTRN	1791	P46939
EGAMHEKLIHELEEE	NCKAP5	66	O14513
MDSDDEMVEEAVEGH	SETD7	1	Q8WTS6
EMVEEAVEGHLDDDG	SETD7	6	Q8WTS6
EDDTIMEELVDNHGK	NANS	341	Q9NR45
DDKSELDMMEGDHTV	TAOK1	376	Q7L7X3
EQLEGEVDHAMELSE	SRCAP	421	Q6ZRS2
GDNSHVEMKLAVDEE	TFRC	31	P02786
QKTDHVALEDEMDAD	ABCA8	446	O94911
QGSDEISHHEKMEEE	CALD1	246	Q05682
EEEMEHQEEGKEQLS	USP4	661	Q13107
EAKESHMVDDASEEL	TRPM6	651	Q9BX84
ENVTDHDISMEEGEK	RALGAPA1	466	Q6GYQ0
HDISMEEGEKREEEN	RALGAPA1	471	Q6GYQ0
RESKVNGDDHHEEDM	SRSF11	466	Q05519
HKQMDDDKDGGIEVE	STIM2	76	Q9P246
ISKDLHDDDEDEEML	PPP1R2B	161	Q6NXS1
DDEEEEEIVHMGNAI	RYR3	2271	Q15413
AVEHMFETEDGSKDE	SPIN1	136	Q9Y657
EEEDHEGDSENKERM	VAT1L	401	Q9HCJ6
HVTDEEIESLMKDGD	TNNC2	126	P02585
KMDEVIESGLVHDFD	UBP1	6	Q9NZI7
MEERKEEGEAEIQEH	TAPR1	1	Q14CZ0
VKVEEEDEEDHMWGQ	ZKSCAN1	26	P17029
GQDEMDELALEDRDH	TRANK1	2646	O15050
KHTEDREEGMDVEEG	THOC1	201	Q96FV9
QHDEHDEDGSDMELD	UBR5	1601	O95071
MDEESLDGLLFKDHD	KLHL38	1	Q2WGJ6
DEAELHEMETEKVSE	KMT2D	1066	O14686